Skip to main content
Back to Mizuho Capital

Mizuho Capital's Biotechnology Portfolio

Browse 6 Biotechnology companies funded by Mizuho Capital. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
6
Total Funding in Biotechnology
$32.2M

Biotechnology Portfolio Companies (6)

Export
Alternative MedicineBiotechnologyPharmaceuticalProduct Research

KAICO is a biotechnology company that provides hard-expressing proteins to develop drugs with a silkworm-baculovirus expression system.

Nishiku, Japan
April 2025
$3.8M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareProduct Research

Luxana Biotech is established to contribute to medical treatment for suffering patients, .

Osaka, Japan
September 2024
$1.7M
Series C

Founder Contacts

19,000+ verified contacts

AgricultureBiotechnologyEnvironmental ConsultingLife Science

GRA&GREEN is a biotechnology company that provides seed development for agriculture, forestry, and raw materials for food processing.

Nagoya, Japan
June 2024
$4.1M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyClinical TrialsMedicalTherapeutics

Metagen Therapeutics is a drug discovery and medical business company that utilizes microbiome science.

Tsuruoka, Japan
February 2026
$7.6M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsPharmaceutical

A-SEEDS is a biotech company that researches and develops regenerative medicines, especially for cancer patients.

Matsumoto, Japan
July 2025
$15.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareLife Science

Modalis is a biotech company that develops therapeutics using CRISPR based technology.

Tokyo, Japan
June 2025
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Explore Mizuho Capital's Full Portfolio

View all companies funded by Mizuho Capital across every industry and funding stage.

View Full Mizuho Capital Portfolio